This Week’s Biotech Highlights

This week was all about looking out vs looking in … navel gazing vs naval gazing, if you will. Let’s spiral in:

Starting all the way in India, we noted concerns that acquisition of Indian companies could lead to higher prices for generic drugs but speculated about some offsetting goo.

Also in India, a story about Glenmark Pharmaceuticals showed how they turned reliable revenue streams into a remarkable focus on innovation, something Canada needs to do as well in the coming years.

A little closer to home, a short article I wrote for Counsel to Counsel Magazine got me thinking about the U.S. healthcare debate, and in particular about how Rawls’ thoughts on a “veil of ignorance” lead to an argument in support of universal healthcare in the genomics era.

And in a final bout of introspection, I launched an experiment in crowdsourcing to start identifying likely biotech trends in 2010. (Note to self: procure crowd.)

Wherever you’re gazing, keep an eye on The Cross-Border Biotech Blogfor everything that’s blog-worthy in the world of biotech and innovation and keep an eye on @crossborderbio on Twitter for all the other news…